You are viewing a free limited preview of 20/20 Gene Systems, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access

20/20 Gene Systems, Inc.

Private Company Ticker Symbol™: (GENSYSP)

Business Summary

20/20 Gene Systems, Inc. is a privately-held biotechnology company. 20/20 Gene Systems specializes in developing and commercializing diagnostic products for early disease detection, therapy selection and biodefense applications. 20/20 Gene Systems generates revenue through the sale of its diagnostic test, PredicTORTM. Founded in 2000, 20/20 Gene Systems headquarters are located in Rockville, Maryland.


Jump to 20/20 Gene Systems, Inc.: Detailed Business Description for more details on 20/20 Gene Systems, Inc. products and services, financial structure, 20/20 Gene Systems, Inc. major business events, and more.

Overview & Corporate Organization

Basic Information

Company Tags:VC Backed
Year Founded:2000
Fiscal Year End:12/31
City:Rockville
State/Province:Maryland
Country:United States
Phone:View
Website:www.2020gene.com

Industry Information

Industry Codes

PICS™:1500113
NAICS:View
SIC:View

PrivCo Industries (Sector > Industry > Sub-Industry)

Technology > Biotechnology > Medical Diagnostic Technology

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

VC/Funding Activity

PrivCo's VC/Funding Activity table for 20/20 Gene Systems, Inc. displays the venture capital rounds, angel investments, debt or other funding raised by 20/20 Gene Systems, Inc..
All data before 2006 is completely free to view! To access data from 2006 onward:
Get Full Access To This Report Now! $99 Single Company Access
 
or Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateInvestorRoundInvestor Type
Aug. 2002Maryland Department of Business and Economic DevelopmentGrantGovernment
Aug. 2002MdBio, Inc.GrantCorporate
Aug. 2002Maryland Technology Development Corporation (TEDCO)GrantBusiness Incubator / SBDC
DetailsTotal Round Grant $250,000
Oct. 2007ViewGrantGovernment
DetailsTotal Round Grant View
Nov. 2007ViewOtherBusiness Incubator / SBDC
DetailsTotal Round Other View
Sep. 2008ViewGrantBusiness Incubator / SBDC
DetailsTotal Round Grant View
Oct. 2011ViewGrantBusiness Incubator / SBDC
DetailsTotal Round Grant View
Total of Funding Shown Above View

Missing a deal? Tell us about it! tips@privco.com

Detailed Business Description: 20/20 Gene Systems, Inc.

PrivCo's Detailed Business Description explains the business operations, products and services, financial structure, and major business milestones of 20/20 Gene Systems, Inc. The first portion of PrivCo's Detailed Business Description is displayed below, free to view to non-subscribers.
To read the entire Detailed Business Description of 20/20 Gene Systems, Inc.:
Get Full Access To This Report Now! $99 Single Company Access
 
or Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!

20/20 Gene Systems, Inc. is a privately held biotechnology company. 20/20 Gene Systems that specializes in developing and commercializing diagnostic products for early disease detection, therapy selection and biodefense applications. 20/20 Gene Systems generates revenue through the sale of companion diagnostic test, PredicTORTM. Founded in 2000, 20/20 Gene Systems is headquartered in Rockville, Maryland.

Company History

2001

20/20 first began sellings its products in late 2001 when the company’s first P-FILM (Protein Function Identification Layered Membranes) product had been sold to nearly 500 drug companies and biomedical research institutes in over 10 countries. P-FILM can be applied to diseased tissue to determine which proteins in the pathway are functioning abnormally and help predict whether a particular drug will effectively treat that disease.

2002

In early 2002, Wako Pure Chemical Industries, Ltd., a subsidiary of Japan’s largest pharmaceutical company, has… Continue Reading →

To continue reading the Detailed Business Description of 20/20 Gene Systems, Inc.:
Get Full Access To This Report Now! $99 Single Company Access
 
or Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!

Supplemental Resources

For additional information on 20/20 Gene Systems, Inc., you can see the following:

You are viewing a free limited preview of 20/20 Gene Systems, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access